A police officer manages people who came to receive a dose of a coronavirus disease vaccine outside a vaccination centre in AhmedabadBENGALURU -Indian drugmaker Zydus Cadila said on Thursday it has applied for emergency use approval of its three-dose COVID-19 vaccine that showed efficacy of 66.6% in an interim study and could become the second home-grown shot if regulators consent.
Zydus' vaccine "will certainly help in ramping up India's overall vaccination drive as it would be the fifth approved," Prashant Khadayate, a pharmaceutical industry analyst at GlobalData said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: